Native Meta creative and exact outbound link observed October 22, 2026. Redirects were followed to the captured public destination. Actual GLP-1 acquisition creative; peptide/sermorelin keyword searches showed no matches. Advertiser claims are source material; activity does not establish performance. No personal, health or payment details were entered.

A long care page develops a direct offer through product quality, treatment comparisons, care steps, customer stories and assessment entry. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
It opens on a moment plenty of people in this market have lived through: the insurance company saying it won't cover the medication. Framing that as a meme, with a grinning reaction photo that has nothing to do with healthcare, makes a frustrating topic feel light and shareable, and it looks like something a friend would post rather than an ad. The payoff is one line, found it out of pocket at Eden, which positions Eden as the workaround for people insurance turned away.
The payoff stops at affordable, and affordable is a word every competitor uses. The person who just got denied coverage wants a number, and this ad has a good one ($99 a dose in the post copy) that never appears on screen. Put the price in the final caption so the joke lands on something concrete. A short no-insurance-needed line, which the landing page already uses next to its button, would also tie the ad's problem straight to the next step.
The mismatch between the happy photo and the denial sets up the joke and names a problem viewers recognize.
It turns the denial into Eden's opening, positioning the brand as the way around insurance.
No price on screen; the video says affordable, while the post copy lists $99 every dose with no hidden fees.
The click goes to Eden's GLP-1 affiliate page, a focused landing page that suits this ad well. The hero shows semaglutide at $99/mo and tirzepatide at $129/mo, and the line under the Start my free assessment button says no insurance needed, which is the direct answer to the insurer in the meme. The plan inclusions section further down explains what the out-of-pocket price covers. A viewer who laughed at the denial lands on a page that gives them the number the ad left out.
Eden's GLP-1 affiliate page is a long, focused landing page that opens on semaglutide at $99/mo and tirzepatide at $129/mo with a free assessment, then covers quality, treatment, care steps, stories and FAQs. All 16 Eden ads in the Fluid library link here, mostly price comparisons plus creator and doctor videos.
The headline, three benefits, both monthly prices and the free assessment button answer what it costs and how to start, with Trustpilot and member-count proof alongside.
It covers where the medication comes from and who oversees care, answering whether a low price means cutting corners.
It explains the problem and how the treatment is meant to work, answering why someone would consider it at all.
It compares treatment options so the visitor can work out which one fits before starting the assessment.
It walks through the steps from assessment to ongoing care, answering what happens after the click.
It shows stories from customers, answering whether people like the visitor have used the service.
It lists what the plan includes and repeats the assessment entry, answering what the monthly price covers right before asking again.
It handles remaining questions and the safety and compounding disclosures, answering the last objections before signing up.
Read the full breakdown of this page
One of 16 Eden ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.